CYTOSORBENTS CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.82 USD | -0.21% |
|
+2.38% | -26.12% |
| Mar. 15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Chart calendar Cytosorbents Corporation
6edf6fc.xld83OHxKrtLUtPn9MvcuZ5zLjXdKbmVuinirf_IZI4.liVMjtiZe94fZ4ygu_jrytQ2VAbwXv6t1W6o2raHI9z1M06ZpYhtzigVlg~3916b3d893a2d0c045870f1411c6d9e4
Upcoming events on Cytosorbents Corporation
Past events on Cytosorbents Corporation
| 2024-03-14 04:39 pm | Q4 2023 Earnings Release |
| 2024-03-14 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-06 11:10 am | TD Cowen Health Care Conference |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-09 04:15 pm | Q3 2023 Earnings Release |
| 2023-10-12 02:30 pm | Dawson James Small Cap Growth Conference |
| 2023-10-06 06:15 am | European Association of Cardio Thoracic Surgery Meeting |
| 2023-08-14 | UBS Medtech Tools and Genomics Summit |
| 2023-08-13 | Military Health System Research Symposium |
| 2023-08-01 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-01 04:15 pm | Q2 2023 Earnings Release |
| 2023-06-09 11:30 am | Jefferies Global Healthcare Conference |
| 2023-06-06 10:00 am | Annual General Meeting |
| 2023-05-02 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-02 04:15 pm | Q1 2023 Earnings Release |
| 2023-03-23 07:30 am | ISICEM Congress |
| 2023-03-09 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-09 04:15 pm | Q4 2022 Earnings Release |
| 2023-03-07 01:30 pm | Cowen Health Care Conference |
| 2022-11-03 04:30 pm | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,9 24,9 0.32% | 41,0 39,7 3.21% | 43,2 42,9 0.7% | 34,7 34,1 1.88% | 36,3 37,5 -3.05% | 40,3 |
|
EBITDA Million USD | Released Forecast Spread | -16,7 -15,8 -5.8% | -5,00 -3,17 -57.64% | -15,8 -10,9 -45.11% | -26,8 -27,7 3.05% | -26,0 -22,8 -14.17% | -16,9 |
|
EBIT Million USD | Released Forecast Spread | -19,0 -18,4 -2.94% | -10,4 -9,44 -9.87% | -22,7 -19,3 -17.68% | -31,5 -31,1 -1.51% | -31,2 -27,1 -15.36% | -21,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,4 -20,8 1.92% | -8,96 -8,98 0.21% | -25,3 -22,1 -14.38% | -33,9 -38,7 12.4% | -29,3 -27,9 -5.04% | -20,8 |
|
Net income Million USD | Released Forecast Spread | -19,3 -20,8 7.18% | -7,84 -8,98 12.76% | -24,6 -21,6 -13.66% | -32,8 -38,7 15.22% | -28,5 -27,9 -2.13% | -20,6 |
|
EPS USD | Released Forecast Spread | -0,60 -0,64 6.61% | -0,20 -0,23 11.39% | -0,57 -0,48 -18.26% | -0,75 -0,89 15.25% | -0,64 -0,62 -3.23% | -0,36 |
| Announcement Date | 05/03/20 | 09/03/21 | 08/03/22 | 09/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10,8 10,8 -0.2% | 8,69 9,97 -12.79% | 8,50 9,56 -11.17% | 8,11 8,52 -4.79% | 9,39 8,75 7.32% | 9,45 8,73 8.19% | 9,42 10,2 -7.65% | 8,81 9,32 -5.44% | 8,67 9,84 -11.91% | 9,78 | 9,85 | 10,1 | 10,6 |
|
EBITDA Million USD | Released Forecast Spread | -8,24 -3,68 -124.28% | -5,04 -5,20 3.14% | -5,48 -4,19 -30.72% | -7,89 -2,94 -168.74% | -5,49 | -4,40 | -2,93 | -3,31 | |||||
|
EBIT Million USD | Released Forecast Spread | -9,56 -6,17 -54.88% | -7,79 -3,55 -119.46% | -8,36 -5,14 -62.66% | -9,02 -6,22 -44.95% | -6,36 -6,07 -4.78% | -7,89 -5,50 -43.49% | -6,56 -6,26 -4.7% | -7,35 -5,67 -29.62% | -9,34 -5,73 -63.02% | -7,19 | -5,06 | -4,96 | -4,98 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,0 -6,88 -45.95% | -8,97 -4,15 -116.05% | -10,9 -5,47 -98.85% | -12,2 -7,05 -72.97% | -1,86 -6,73 72.39% | -7,33 -6,10 -20.1% | -6,15 -6,31 2.56% | -9,19 -5,53 -66.31% | -6,65 -5,69 -16.74% | -7,12 | -4,99 | -4,89 | -4,91 |
|
Net income Million USD | Released Forecast Spread | -9,31 -6,37 -46.15% | -8,97 -4,15 -116.05% | -10,9 -5,47 -98.85% | -12,2 -7,05 -72.97% | -0,77 -6,73 88.61% | -7,33 -6,10 -20.1% | -6,15 -6,31 2.56% | -9,19 -5,53 -66.31% | -5,83 -5,69 -2.45% | -7,12 | -4,99 | -4,89 | -4,91 |
|
EPS USD | Released Forecast Spread | -0,21 -0,13 -59.09% | -0,21 -0,14 -50% | -0,25 -0,12 -102.71% | -0,28 -0,16 -71.43% | -0,01 -0,15 93.44% | -0,17 -0,13 -34.21% | -0,14 -0,14 -2.44% | -0,21 -0,12 -75% | -0,12 -0,11 -9.09% | -0,12 | -0,10 | -0,08 | -0,06 |
| Announcement Date | 08/03/22 | 03/05/22 | 02/08/22 | 03/11/22 | 09/03/23 | 02/05/23 | 01/08/23 | 09/11/23 | 14/03/24 | - | - | - | - |
More events
Past sector events for Cytosorbents Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTSO Stock
- Calendar Cytosorbents Corporation
